Patents by Inventor Brent Matthew Healy

Brent Matthew Healy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11782296
    Abstract: Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: October 10, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Publication number: 20210263340
    Abstract: Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.
    Type: Application
    Filed: May 12, 2021
    Publication date: August 26, 2021
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 11029539
    Abstract: Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: June 8, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 10871595
    Abstract: Provided are compositions comprising a block copolymer of the following formula: [A]-B-[Q], wherein [A] is a polymer that has an affinity for a substrate; B is a linking group comprising an optionally-substituted, polyvalent linking group having a molecular weight of no more than 1000 g/mole; and [Q] comprises a semi-crosslinked, ungelled polymer derived from copolymerization of an ethylenically unsaturated monomer with a poly-functional ethylenically unsaturated monomer. Such block copolymers are cross-linked via the [Q] segment, but not macroscopically gelled. The [Q] segment is hydrophilic and has a degree of polymerization in the range of about 10 to about 10,000. The [A] segment is located on at least one terminal end of said block copolymer, comprises between about 1 and about 200 repeating units. The block copolymer is associated, via the linear substrate associative segment with a surface comprising at least one hydrophobic site, such as a silicone hydrogel.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: December 22, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Publication number: 20200050021
    Abstract: Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.
    Type: Application
    Filed: October 18, 2019
    Publication date: February 13, 2020
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Publication number: 20200049858
    Abstract: Provided are compositions comprising a block copolymer of the following formula: [A]-B-[Q], wherein [A] is a polymer that has an affinity for a substrate; B is a linking group comprising an optionally-substituted, polyvalent linking group having a molecular weight of no more than 1000 g/mole; and [Q] comprises a semi-crosslinked, ungelled polymer derived from copolymerization of an ethylenically unsaturated monomer with a poly-functional ethylenically unsaturated monomer. Such block copolymers are cross-linked via the [Q] segment, but not macroscopically gelled. The [Q] segment is hydrophilic and has a degree of polymerization in the range of about 10 to about 10,000. The [A] segment is located on at least one terminal end of said block copolymer, comprises between about 1 and about 200 repeating units. The block copolymer is associated, via the linear substrate associative segment with a surface comprising at least one hydrophobic site, such as a silicone hydrogel.
    Type: Application
    Filed: October 22, 2019
    Publication date: February 13, 2020
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 10502867
    Abstract: Provided are compositions comprising a block copolymer of the following formula: [A]-B-[Q], wherein [A] is a polymer that has an affinity for a substrate; B is a linking group comprising an optionally-substituted, polyvalent linking group having a molecular weight of no more than 1000 g/mole; and [Q] comprises a semi-crosslinked, ungelled polymer derived from copolymerization of an ethylenically unsaturated monomer with a poly-functional ethylenically unsaturated monomer. Such block copolymers are cross-linked via the [Q] segment, but not macroscopically gelled. The [Q] segment is hydrophilic and has a degree of polymerization in the range of about 10 to about 10,000. The [A] segment is located on at least one terminal end of said block copolymer, comprises between about 1 and about 200 repeating units. The block copolymer is associated, via the linear substrate associative segment with a surface comprising at least one hydrophobic site, such as a silicone hydrogel.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: December 10, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 10502978
    Abstract: Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: December 10, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 10301465
    Abstract: The present invention relates to compositions comprising at least one stable, near-monodisperse, non-reactive hydrophilic polymer comprising in said polymer's backbone, a hydrophilic segment having a degree of polymerization of about 10 to about 1000, and a linear silicone segment at at least one terminal end of said non-reactive hydrophilic polymer, wherein said silicone segment comprises between about 6 and about 200 siloxy units, and said non-reactive hydrophilic polymer is associated, via the linear silicone block with a silicone hydrogel. The non-reactive hydrophilic polymers may be incorporated into the formulation from which the silicone hydrogel is made or may be contacted with the silicone hydrogel post formation.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: May 28, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles Scales, Kunisi Venkatasubban, Shivkumar Mahadevan, Zohra Fadli, Carrie Davis, Brent Matthew Healy
  • Publication number: 20180341044
    Abstract: Provided are compositions comprising a block copolymer of the following formula: [A]-B-[Q], wherein [A] is a polymer that has an affinity for a substrate; B is a linking group comprising an optionally-substituted, polyvalent linking group having a molecular weight of no more than 1000 g/mole; and [Q] comprises a semi-crosslinked, ungelled polymer derived from copolymerization of an ethylenically unsaturated monomer with a poly-functional ethylenically unsaturated monomer. Such block copolymers are cross-linked via the [Q] segment, but not macroscopically gelled. The [Q] segment is hydrophilic and has a degree of polymerization in the range of about 10 to about 10,000. The [A] segment is located on at least one terminal end of said block copolymer, comprises between about 1 and about 200 repeating units. The block copolymer is associated, via the linear substrate associative segment with a surface comprising at least one hydrophobic site, such as a silicone hydrogel.
    Type: Application
    Filed: August 3, 2018
    Publication date: November 29, 2018
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 10073192
    Abstract: Provided are compositions comprising a block copolymer of the following formula: [A]-B-[Q], wherein [A] is a polymer that has an affinity for a substrate; B is a linking group comprising an optionally-substituted, polyvalent linking group having a molecular weight of no more than 1000 g/mole; and [Q] comprises a semi-crosslinked, ungelled polymer derived from copolymerization of an ethylenically unsaturated monomer with a poly-functional ethylenically unsaturated monomer. Such block copolymers are cross-linked via the [Q] segment, but not macroscopically gelled. The [Q] segment is hydrophilic and has a degree of polymerization in the range of about 10 to about 10,000. The [A] segment is located on at least one terminal end of said block copolymer, comprises between about 1 and about 200 repeating units. The block copolymer is associated, via the linear substrate associative segment with a surface comprising at least one hydrophobic site, such as a silicone hydrogel.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 11, 2018
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Publication number: 20180044518
    Abstract: The present invention relates to compositions comprising at least one stable, near-monodisperse, non-reactive hydrophilic polymer comprising in said polymer's backbone, a hydrophilic segment having a degree of polymerization of about 10 to about 1000, and a linear silicone segment at at least one terminal end of said non-reactive hydrophilic polymer, wherein said silicone segment comprises between about 6 and about 200 siloxy units, and said non-reactive hydrophilic polymer is associated, via the linear silicone block with a silicone hydrogel. The non-reactive hydrophilic polymers may be incorporated into the formulation from which the silicone hydrogel is made or may be contacted with the silicone hydrogel post formation.
    Type: Application
    Filed: October 3, 2017
    Publication date: February 15, 2018
    Inventors: Charles Scales, Kunisi Venkatasubban, Shivkumar Mahadevan, Zohra Fadli, Brent Matthew Healy
  • Patent number: 9815979
    Abstract: The present invention relates to compositions comprising at least one stable, near-monodisperse, non-reactive hydrophilic polymer comprising in said polymer's backbone, a hydrophilic segment having a degree of polymerization of about 10 to about 1000, and a linear silicone segment at at least one terminal end of said non-reactive hydrophilic polymer, wherein said silicone segment comprises between about 6 and about 200 siloxy units, and said non-reactive hydrophilic polymer is associated, via the linear silicone block with a silicone hydrogel. The non-reactive hydrophilic polymers may be incorporated into the formulation from which the silicone hydrogel is made or may be contacted with the silicone hydrogel post formation.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: November 14, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles Scales, Kunisi Venkatasubban, Shivkumar Mahadevan, Zohra Fadli, Brent Matthew Healy
  • Publication number: 20170299894
    Abstract: Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.
    Type: Application
    Filed: June 30, 2017
    Publication date: October 19, 2017
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 9726906
    Abstract: Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: August 8, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Patent number: 9625617
    Abstract: The present invention relates to biomedical devices, and particularly contact lenses comprising a polymer having entangled therein at least one polymer comprising repeating units from N-(2-hydroxyalkyl)(meth)acrylamide.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: April 18, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
  • Publication number: 20170051145
    Abstract: The present invention relates to compositions comprising at least one stable, near-monodisperse, non-reactive hydrophilic polymer comprising in said polymer's backbone, a hydrophilic segment having a degree of polymerization of about 10 to about 1000, and a linear silicone segment at at least one terminal end of said non-reactive hydrophilic polymer, wherein said silicone segment comprises between about 6 and about 200 siloxy units, and said non-reactive hydrophilic polymer is associated, via the linear silicone block with a silicone hydrogel. The non-reactive hydrophilic polymers may be incorporated into the formulation from which the silicone hydrogel is made or may be contacted with the silicone hydrogel post formation.
    Type: Application
    Filed: November 4, 2016
    Publication date: February 23, 2017
    Inventors: Charles Scales, Kunisi Venkatasubban, Shivkumar Mahadevan, Zohra Fadli, Brent Matthew Healy
  • Patent number: 9522980
    Abstract: The present invention relates to compositions comprising at least one stable, near-monodisperse, non-reactive hydrophilic polymer comprising in said polymer's backbone, a hydrophilic segment having a degree of polymerization of about 10 to about 1000, and a linear silicone segment at least one terminal end of said non-reactive hydrophilic polymer, wherein said silicone segment comprises between about 6 and about 200 siloxy units, and said non-reactive hydrophilic polymer is associated, via the linear silicone block with a silicone hydrogel. The non-reactive hydrophilic polymers may be incorporated into the formulation from which the silicone hydrogel is made or may be contacted with the silicone hydrogel post formation.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: December 20, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Charles Scales, Kunisi Venkatasubban, Shivkumar Mahadevan, Zohra Fadli, Carrie Davis, Brent Matthew Healy
  • Patent number: 9459377
    Abstract: The present invention relates to a polymers and hydrogels comprising a sulfonic acid component formed from reactive components comprising (i) at least one hydrophobic monomer and (ii) at least one sulfonic acid-containing component, wherein the sulfonic acid-containing component is comprised of a salt formed by a non-polymerizable, hydrophilic base and a polymerizable sulfonic acid. One or more embodiments provide that the at least one hydrophobic monomer comprises a silicone component.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: October 4, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Thomas L. Maggio, Brent Matthew Healy, Leilani K. Sonoda, Michelle Carman Turnage, Hemantkumar Vashi
  • Publication number: 20160161639
    Abstract: The present invention relates to biomedical devices, and particularly contact lenses comprising a polymer having entangled therein at least one polymer comprising repeating units from N-(2-hydroxyalkyl)(meth)acrylamide.
    Type: Application
    Filed: February 17, 2016
    Publication date: June 9, 2016
    Inventors: Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy